A new drug to treat heart failure

Most people with heart failure (or those at high risk for it) need several medications to treat their symptoms. New guidelines from the American College of Cardiology/American Heart Association have added another drug class to the treatment list: a group of diabetes drugs called sodium-glucose cotransporter-2 (SGLT-2) inhibitors. SGLT-2 inhibitors offer multiple benefits, such as helping to reduce swelling, lowering high blood pressure, assisting with weight loss, reducing complications associated with heart failure, and preventing hospitalization.